Sheri L. Koshman - Concepedia

Author

Sheri L. Koshman

University of Alberta ORCID

Also Known As

S Koshman, S. Koshman, S.L. Koshman, Sheri Koshman, Sheri L Koshman, Sheri L. Koshman

Publications

2.9K

Citations

H-Index

Concepts

All Affiliations

University of Alberta University of British Columbia University of Calgary Alberta Health Services St. Boniface Hospital

About

Sheri L. Koshman is an author at University of Alberta specializing in medicine, cardiovascular disease, and heart failure.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	968
2	Public Health	3	3	711
3	Emergency Medicine	2	2	129
4	Health Policy	2	2	692
5	Family Medicine	1	1	14

Sheri L. Koshman

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure Justin A. Ezekowitz, Eileen O’Meara, Michael McDonald, Canadian Journal of Cardiology Heart FailureCardiovascular DiseaseHealth PolicyCardiac CarePreventive Cardiology	2017	678
Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity Edith Pituskin, John R. Mackey, Sheri L. Koshman, Journal of Clinical Oncology	2017	386
CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis Eileen O’Meara, Michael McDonald, Michael Chan, Canadian Journal of Cardiology CardiomyopathyHeart FailureCardiorenal SyndromesCardiovascular DiseaseStructural Heart Disease	2020	120
Capturing Outcomes of Clinical Activities Performed by a Rounding Pharmacist Practicing in a Team Environment Mark Makowsky, Sheri L. Koshman, William K. Midodzi, Medical Care	2009	117
Association of Ticagrelor vs Clopidogrel With Major Adverse Coronary Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention Ricky D. Turgeon, Sheri L. Koshman, Erik Youngson, JAMA Internal Medicine	2020	114
The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: Anemia, Biomarkers, and Recent Therapeutic Trial Implications Gordon W. Moe, Justin A. Ezekowitz, Eileen O’Meara, Canadian Journal of Cardiology Heart FailureCardiovascular DiseaseCardiac CarePreventive CardiologyMedicine	2014	110
Rationale and design of the Multidisciplinary Approach to Novel Therapies in Cardiology Oncology Research Trial (MANTICORE 101 - Breast): a randomized, placebo-controlled trial to determine if conventional heart failure pharmacotherapy can prevent trastuzumab-mediated left ventricular remodeling among patients with HER2+ early breast cancer using cardiac MRI Edith Pituskin, Mark J. Haykowsky, John R. Mackey, BMC Cancer	2011	87
Supratherapeutic Response to Ezetimibe Administered with Cyclosporine Sheri L. Koshman, Lucille D. Lalonde, Ilene Burton, Annals of Pharmacotherapy	2005	35
Cardiac and cardiometabolic phenotyping of trastuzumab-mediated cardiotoxicity: a secondary analysis of the MANTICORE trial Amy A. Kirkham, Edith Pituskin, Richard B. Thompson, European Heart Journal - Cardiovascular Pharmacotherapy	2021	35
Independent prescribing by hospital pharmacists: Patterns and practices in a Canadian province Taryn Heck, Mary Gunther, Lauren Bresee, American Journal of Health-System Pharmacy	2015	20

Page 1